Teva Pharmaceuticals USA, Inc recalls Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen)
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
- Products
-
- Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen)
- Where it was sold
-
nationwide
Nationwide
- Units affected
- 19,824 cartons
- About this recall
- Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen), packaged in cartons, each carton contains 6 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9012-58